Mabasa et al. [28] noted a reduction in liver weight and hepatic steatosis in db/db mice treated with SB, along with a downregulation of Fasn, a gene involved in lipid synthesis, suggesting that SB may influence lipid metabolism at the genetic level. The gene discussed is FASN; the disease is fatty liver disease.